PNC Financial Services Group’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
EAM
ACG
JMFC
PNC Financial Services Group's DNA Position: Q2 2026 in Review
PNC Financial Services Group increased its Ginkgo Bioworks (DNA) stake by 24% in Q2 2026, buying an estimated $711 and bringing the position to 444 shares worth $4.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4438.
PNC Financial Services Group first reported a position in DNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $142K in Q3 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.
- PNC Financial Services Group held 444 shares of Ginkgo Bioworks worth $4.4K as of Q2 2026.
- PNC Financial Services Group bought 85 Ginkgo Bioworks shares in Q2 2026, an estimated $711.
- Ginkgo Bioworks made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4438 holding.
- PNC Financial Services Group first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 19 quarters since.
- PNC Financial Services Group's Ginkgo Bioworks position peaked at $142K in Q3 2022.
- 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.